Health

Nurses to Testify Tuesday at State House on Bills to Protect Patients from Unsafe Medication Administration and Caretakers During Emergency Response

Monday, November 18, 2019 - 4:33pm

Charlie Baker proposed regulation changes that could have opened the door to unlicensed personnel administering complex medication to patients in many different healthcare settings.

Key Points: 
  • Charlie Baker proposed regulation changes that could have opened the door to unlicensed personnel administering complex medication to patients in many different healthcare settings.
  • Chapter 94C) that could result in the use of unlicensed persons administering medication in the interest of efficiency or cost savings.
  • The bill would protect nurses who are injured or harmed personally as the result of his/her volunteer service.
  • Founded in 1903, the Massachusetts Nurses Association is the largest union of registered nurses in the Commonwealth of Massachusetts.

Asia Pacific Spinal Cord Stimulation Devices Market Estimated to Grow with a CAGR of 9.3%, 2019-2025 - ResearchAndMarkets.com

Monday, November 18, 2019 - 6:58pm

The "Asia Pacific Spinal Cord Stimulation Devices Market 2019-2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Spinal Cord Stimulation Devices Market 2019-2025)" report has been added to ResearchAndMarkets.com's offering.
  • The growing geriatric population and favorable reimbursement and insurance approval measures are key variables influencing the rise of this industry.
  • Besides, the introduction of new methods in minimally invasive surgery will generate profitable possibilities for core participants in the market.
  • Stimulation of the spinal cord has been in therapy use for almost 50 years.

Karen Hornsby Joins Advanced Dermatology and Cosmetic Surgery as Chief Managed Care Officer

Monday, November 18, 2019 - 7:00pm

Advanced Dermatology and Cosmetic Surgery (ADCS), one of the nations leaders in high-quality dermatology, today announced the appointment of Karen Hornsby as Chief Managed Care Officer effective November 18, 2019.

Key Points: 
  • Advanced Dermatology and Cosmetic Surgery (ADCS), one of the nations leaders in high-quality dermatology, today announced the appointment of Karen Hornsby as Chief Managed Care Officer effective November 18, 2019.
  • Most recently she was Vice President of Managed Care for Envision Healthcare, where she directed all regional managed care operations for the firms hospital-based physicians and ambulatory surgery centers.
  • Advanced Dermatology and Cosmetic Surgery supports a great portfolio of high quality practices concentrated in attractive markets, which is very attractive to patients and payors alike, said Ms. Hornsby.
  • Advanced Dermatology and Cosmetic Surgery is the largest dermatology practice in the country.

Asia-Pacific Respiratory Syncytial Virus Market: Epidemiology Forecast to 2028 - ResearchAndMarkets.com

Monday, November 18, 2019 - 6:31pm

The "Respiratory Syncytial Virus: Epidemiology Forecast in Asia-Pacific Markets to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Syncytial Virus: Epidemiology Forecast in Asia-Pacific Markets to 2028" report has been added to ResearchAndMarkets.com's offering.
  • Respiratory syncytial virus (RSV) is a common respiratory infection that most children will be infected with by the time they are two years old.
  • The Respiratory Syncytial Virus (RSV) Epidemiology Report and Model provide an overview of the risk factors and global trends RSV in the five growth markets (5GM: Japan, Australia, urban China, India, and South Korea).
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 5GM.

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells

Monday, November 18, 2019 - 6:19pm

Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering with Type I CRISPR-Cas systems.

Key Points: 
  • Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering with Type I CRISPR-Cas systems.
  • The study, entitled Harnessing Type I CRISPR-Cas Systems for Genome Engineering in Human Cells, was published today in the peer-reviewed scientific journal Nature Biotechnology.
  • In the study, Caribou researchers and their collaborators tested whether the multi-protein Class 1 Type I CRISPR-Cas system could be harnessed for human genome engineering.
  • Caribou Biosciences and the Caribou logo are registered trademarks of Caribou Biosciences, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20191118005727/en/

Mannatech Declares Third Quarter 2019 Dividend

Monday, November 18, 2019 - 7:00pm

The dividend reflects a commitment to rewarding shareholders and encouraging long-term investment in Mannatechs common stock.

Key Points: 
  • The dividend reflects a commitment to rewarding shareholders and encouraging long-term investment in Mannatechs common stock.
  • Alfredo Al Bala, President and CEO of Mannatech, said, Mannatech is fully committed to delivering value to our shareholders.
  • The company's strengths, including the potency of our products and the quality of our sales force, position the company well to support a dividend.
  • ^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.

Global Healthcare Cloud Computing Market 2018-2022 | Introduction of Blockchain in Cloud Computing to Boost Growth | Technavio

Monday, November 18, 2019 - 6:30pm

View the full release here: https://www.businesswire.com/news/home/20191118005691/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191118005691/en/
    Technavio has announced its latest market research report titled global healthcare cloud computing market 2018-2022.
  • Thus, growing collaborations among different stakeholders of the healthcare industry will drive the healthcare cloud computing market.
  • Global Healthcare Cloud Computing Market: Introduction of Blockchain in Cloud Computing
    Rising deployment of cloud computing systems in the healthcare industry has resulted in an increase in data and information theft, resulting in cybersecurity issues.
  • Global Healthcare Cloud Computing Market: Segmentation Analysis
    This market report segments the global healthcare cloud computing market by product (SaaS, IaaS, and PaaS) and geography (Americas, APAC, and EMEA).

Global Engineering Services Market 2018-2022 | Proliferation of Advanced Technologies to Boost Growth | Technavio

Monday, November 18, 2019 - 7:00pm

The global engineering services market is expected to post a CAGR of nearly 4% during the period 2018-2022, according to the latest market research report by Technavio.

Key Points: 
  • The global engineering services market is expected to post a CAGR of nearly 4% during the period 2018-2022, according to the latest market research report by Technavio.
  • View the full release here: https://www.businesswire.com/news/home/20191118005628/en/
    Technavio has announced its latest market research report titled global engineering services market 2018-2022.
  • Thus, the increased deployment of engineering services due to its ability to reduce overhead cost will boost the global market growth.
  • This market research report segments the global engineering services market by end-user (telecommunication, automotive, healthcare, and others) and geographical regions (APAC, Americas, and EMEA).

Cerapedics Announces FDA Approval of PMA Supplement Based on Two-Year Clinical Data

Monday, November 18, 2019 - 3:34pm

Cerapedics requested approval for an updated package insert that incorporates the 24-month follow-up data from subjects enrolled in the original clinical study.

Key Points: 
  • Cerapedics requested approval for an updated package insert that incorporates the 24-month follow-up data from subjects enrolled in the original clinical study.
  • "We are pleased to receive FDA approval of our PMA supplement, which allows i-FACTOR labeling to reflect longer-term clinical data showing that the statistical superiority to autologous bone in overall clinical success that was observed at one year has been maintained at two-year follow up," said Jeffrey Marx, Ph.D., President and Chief Operating Officer of Cerapedics.
  • We are very excited about FDA's approval of our label expansion which further validates the long-term safety and efficacy of i-FACTOR."
  • It is in a new category of bone graft technology and is one of only two drug-device combination products approved by the FDA.

Remedy and Regence Collaborate on Innovative Member-Centered Program Using Episodes of Care

Monday, November 18, 2019 - 3:30pm

"We're honored to support Regence's groundbreaking Episodes of Care program," said Kyle Armbrester, CEO of Remedy.

Key Points: 
  • "We're honored to support Regence's groundbreaking Episodes of Care program," said Kyle Armbrester, CEO of Remedy.
  • Episodes of Care puts Regence at the forefront of innovation in how to pay for health care.
  • Remedy is America's leading episodes of care company, which connects employers, insurance companies, and health care systems to deliver more cost-effective care and improved consumer experiences.
  • Remedy delivers software and services enabling health care providers and health insurers to organize and finance health care around patient episodes of care.